Actively Recruiting
FlexWave Trial: Efficacy of Extracorporeal Shock Wave Therapy in Post-Stroke Upper Limb Spasticity
Led by National Taiwan University Hospital · Updated on 2025-07-29
40
Participants Needed
1
Research Sites
156 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Extracorporeal shock wave therapy (ESWT) has emerged as an effective therapeutic intervention for addressing post-stroke limb spasticity. This research aims to explore the therapeutic implications of focused ESWT for wrist and finger flexor muscles in patients suffering from post-stroke upper limb spasticity.
CONDITIONS
Official Title
FlexWave Trial: Efficacy of Extracorporeal Shock Wave Therapy in Post-Stroke Upper Limb Spasticity
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Individuals aged 18 years or older with unilateral cerebral stroke
- Wrist and finger flexor muscle tone with a score greater than 1 on the Modified Ashworth Scale
- Stable medical condition and vital signs
- Conscious and able to comply with instructions
You will not qualify if you...
- History of more than one stroke, traumatic brain injury, or cerebral neoplasm
- Coexisting central nervous system disorders such as spinal cord injury or Parkinson's disease
- Other musculoskeletal diseases affecting muscle tone assessment
- Contraindications for shockwave therapy including malignancies, bleeding disorders, local infections, or cardiac pacemaker use
- Received shockwave therapy or botulinum toxin injections for post-stroke spasticity within the past three months
- Cognitive, consciousness, or language impairments that interfere with participation or assessments
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Department of Physical Medicine & Rehabilitation , National Taiwan University Hospital
Taipei, Taipei, Taiwan, 100
Actively Recruiting
Research Team
S
Shu-mei Yang, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here